APA (7th ed.) Citation

Sinha, P., Mostaghim, A., Bielick, C. G., McLaughlin, A., Hamer, D. H., Wetzler, L. M., . . . Sagar, M. (2020). Early administration of interleukin-6 inhibitors for patients with severe COVID-19 disease is associated with decreased intubation, reduced mortality, and increased discharge. Elsevier.

Chicago Style (17th ed.) Citation

Sinha, Pranay, et al. Early Administration of Interleukin-6 Inhibitors for Patients with Severe COVID-19 Disease Is Associated with Decreased Intubation, Reduced Mortality, and Increased Discharge. Elsevier, 2020.

MLA (8th ed.) Citation

Sinha, Pranay, et al. Early Administration of Interleukin-6 Inhibitors for Patients with Severe COVID-19 Disease Is Associated with Decreased Intubation, Reduced Mortality, and Increased Discharge. Elsevier, 2020.